Inhibition of gene expression by antlsense oligonucleotides Is limited by their low ability to enter cells. Knowing that sugar binding receptors, also called membrane lectlns, efficiently Internalize neoglycoproteins bearing the relevant sugar, 6-phosphomannose, for instance, oligonucleotides-substituted on their 5'-end with either a fluorescent probe or a radioactive label on the one hand, and bearing a thiol function on their 3'-end, on the other hand,-were coupled onto 6-phosphomannosylated proteins via a disulfide bridge. The oligonucleotlde bound to 6-phosphomannosylated serum albumin is much more efficiently internalized roughly 20 times than the free oligonucleotlde. Although most of the oligonucleotides are associated with vesicular compartments, oligonucleotides after releasing from the carrier by reduction of the disulfide bridge may find their way to reach the cytosol and then lead to an increase In the efficiency of the oligonucleotides.
INTRODUCTION
Antisense oligodeoxyribonucleotides have been reported to act in in vitro experiments as inhibitors, for virus or cellular gene expression by forming hybrids with mature mRNAs or premRNAs (for reviews see: 1,2). The major limitation of a putative use of unmodified antisense oligonucleotides as therapeutic agents are their low ability to enter cells. Oligonuleotides have been shown to be taken up by cultured cells through a saturable and energy dependent process putativly mediated by a membrane receptor or transporter, but this process does not allow the concentration of the oligonucleotides inside the cells and therefore leads to low intracellular concentrations (3, 4) .
Several modifications have been proposed to increase the intracellular concentration of oligonucleotides. When oligonucleotides are substituted with hydrophobic compounds such as acridine (5) , cholesterol (6, 7) , alkyl chain (8, 9) or lipid (10) or bound to a polycation such as poly(L-lysine) (11) (12) (13) their penetration into cells and or their biological activity are improved.
Cells expressed surface receptors mediating endocytosis of their ligands, receptor-specific macromolecular carriers are good candidates to target oligonucleotides to selected cells and to increase their accumulation in intracellular compartments. Amongst cell surface receptors, various sugar binding receptors (so called membrane lectins) have been characterized at the cell surface of a large number of normal and malignant cells (for reviews see: [14] [15] [16] [17] . These cell surface receptors specifically bind and internalize glycoproteins and neoglycoproteins bearing an appropriate sugar residue. For instance, hepatocytes express a galactose specific membrane lectin (18) , macrophages a mannose specific membrane lectin (19, 20) but also a mannose-6-phosphate specific membrane lectin (21) . Monocytes which lack the mannose receptor express the mannose-6-phosphate specific membrane lectin (22) ; after few days in culture, monocyte derived macrophages bind and internalize with a great efficacy neoglycoproteins bearing either mannose or mannose-6-phosphate residues. Two mannose-6-phosphate receptors have been characterized: a 275 000 Mr receptor which bind M6P even in absence of cation is a membrane lectin involved both in lysosomal enzyme trafficking and in the endocytic pathway and a 46 000 Mr receptor which requires calcium or other divalent cations to bind M6P and glycoproteins bearing M6P (23) , is a membrane lectin only involved in the intracellular trafficking.
Neoglycoproteins (serum albumin substituted with glycosides) and glycosylated neutral polymers (gluconoylated poly-L-lysine substituted with glycosides) which are specifically recognized and endocytosed by membrane lectins, have been used as drug carriers. Cytotoxic drugs and antiviral drugs have been targeted to malignant cells (24) (25) (26) or virus-infected hepatocytes (27 and references therein), but the main successfull targeting was achieved with macrophages and macrophage lineage cells. Macrophages can be activated and become tumoricidal both in vitro and in vivo by muramyldipeptide bound to neoglycoproteins or polymers bearing mannose residues at concentrations 100 to 1000-fold less than when free muramyldipeptide is used (28) (29) (30) (31) . Macrophages serve as a host for a large number of intracellular pathogens, parasites and viruses: recently it was shown that antiparasite and antiviral drugs bound to glycosylated carriers had a better activity that the related free drug (32, 33) . On these bases, such drug delivery system could selectively enhance oligonucleotide uptake by macrophages.
As macrophages act as a reservoir for HTV (for a review see 34), we decided to target antisense oligonucleotides by using glycosylated macromolecular carriers.
The oligonucleotide was substituted at both 3'-and 5'-ends in order to increase its stability and to allow its linkage to the neoglycoprotein on one hand and the addition of a fluorescent or radioactive probe on the other hand. In the oligonucleotide neoglycoprotein conjugates, the oligonucleotide 5'-end is substituted either with a fluoresceinyl residue or with a 12J I iodo-tyramine residue, the oligonucleotide 3'-end is linked through a disulfide bridge to the neoglycoprotein. The binding and internalization of oligonucleotideneoglycoprotein conjugates were assessed using peritoneal mouse macrophages as well as immortalized cell lines as models:-a murine macrophage cell line, clone J774 E which is a variant of the J774 cells obtained by Diment et al and choosen because this clone expresses the mannose specific lectin (35) as well as the cation independent M6P specific lectin (unpublished results),-U937, human promonocyte cell line and -BHK cells, fibroblast like cell line known to express the cation independent M6P specific membrane lectin (36) .
In this paper, we describe the preparation of oligonucleotideneoglycoprotein conjugates and we determine the cell association and the internalization of the oligonucleotides and the neoglycoprotein conjugates and we study the intracellular localization of these conjugates. For the reasons indicated above, the carrier is a protein substituted with mannose-6-phosphate residues, M6P-BSA which bind to and is internalized by cells expressing mannose-6-phosphate specific membrane lectins. The oligonucleotide is a 19 mer 2 deoxy-/3-ribonucleotide, which hybridizes the [+64 +83] sequence of HTV-1 Bru LTR (37) and inhibits the expression of a reporter enzyme in cells transfected with constructs containing LTR linked to the cDNA of that enzyme (38) . This 19 mer was selected as a model for further investigation on the biological activity of the oligonucleotide conjugates.
We show that the intracellular concentration of the 19mer oligonucleotide was much higher when the cells were incubated with the oligonucleotide bound to the 6-phosphomannosidebearing neoglycoprotein than when the cells were incubated either with the free oligonucleotide or with the oligonucleotide bound to sugar-free albumin. I Na from (Amersham, Buckinghamshire, UK), Af-succinimidyl 3-(2-pyridyldithio)propionate (SPDP), 4-succinimidyloxycarbonyl-a-methyl-a-(2-pyridinyldithio)-toluene (SMPT) and Iodogen from Pierce (Rockford, IL, USA). Enzymes, Penicillium citrium nuclease PI and calf intestine alcaline phosphatase were obtained from Boehringer (Mannhein, Germany). Biogel P-2 was purchased from Bio-Rad (Richmond, CA, USA); Trisacryl GF05 from Sepracor (Villeuneuve-la Garenne, France) and G-75 from Pharmacia (Uppsala, Sweden). The neoglycoprotein M6P-BSA was prepared by coupling 16 A^-[/KO-6^C)spho-a-I>nTannopyranosyl)phenyl]thiocarbamyl groups to BSA according to Roche et al (22) . All solvents were dried and distilled before use.
MATERIALS AND METHODS
Oligodeoxyribonucleotides were synthesized on a Milligen DNA synthesizer 75000 (Milligen, St Quentin en Yvelines, France) using the phosphoramidite method (39 (Fig 1) (40) . Detritylated 5'-end of the otherwise fully protected oligomer 1 (uncleaved from the support) was activated for 5 h at 20°C with 1.5 mmol 1,1'-carbonyldiimidazole (CDI) in 5 ml dioxane to afford compound 2 which then reacted for 12 h with 2.75 mmol hexamethylene diamine in 5 ml pyridine (41) . After cleavage from the support and deprotection with concentrated ammonia for 12 h at 50°C, the oligonucleotide 3, 5' aminohexylamino carbonyl, 3'disulfide bridge nonadecamer, NH 2 -(CH 2 ) 6 
CH2)2-OH was purified by ion exchange chromatography on a Mono P 5/5 column equilibrated with a mixture of 0.01 M phosphate buffer, pH 6.8 and of CH 3 CN (4:1; vol/vol). The product was eluted with a linear gradient from 0 to 1.5 M NaCl in 20 min (Rt 3 = 14.8 min, flow rate 1/il/min). CH3CN was evaporated under reduced pressure and compound 3 was desalted on Biogel P2column eluted with ditilled water and freeze-dried. Fluorescein isothiocyanate (FITC, 10 /tmol in 200 /J DMF) reacted for 5 h at 20°C with the amino group linked to the 5'-end of 3 (0.5 /tmol) in 2 ml of 0.1 M carbonate/bicarbonate buffer, pH 9.5. Then, 0.7 ml 4M ammonium acetate was added and the oligonucleotide derivative was purified by precipitation from its aqueous solution by adding 10 volumes of ethanol in order to remove the excess of free fluorescein isothiocyanate remaining in the supernatant. The pure compound 4 (F-19mer-RSSR-OH) with R= -(CH 2 ) 2 7 . Tyramine (3.5 mmol in 5 ml dry pyridine) reacted for 12 h at 20°C with the nonadecamer 2 activated on its 5'-end. The excess of tyramine was removed by several washing of the resin with pyridine and the oligonucleotide was cleaved from the support and deprotected by treatment for 12 h at 50°C with concentrated ammonia as described above. The compound 6 (Tya-19mer-RSSR-OH) with R= -(CH^-CHCH^-CKCH^-was precipitated by adding 10 volumes ethanol and purified by reverse phase chromatography on Lichrocart (12.5cm X4cm) packed with 5m m Lichrospher RP18 (Merck) using a linear gradient of CH 3 CN (5 to 27.5%) in 0.1 M TEAA buffer, pH 7.0 (R\<,= 17.8 min, flow rate 4 /tl/min), desalted on Biogel P 2 column eluted with distilled water and finally freeze-dried. The compound 6 was iodinated using iodogen as oxidative reagent (42) . I25 I Na (37 MBq) was added to 0.15 /xmol oligonucleotide in 100 /il PBS and the mixture was stirred for 10 min at 20°C. The reaction was stopped by addition of 100 ml tyrosine 1 mM in PBS. After 10 min, the radiolabelled oligomer 7 (*Tya-19mer-RSSR-OH, 440 MBq//imol) was purified by gel filtration on a Biogel P2 column equilibrated with PBS. The same procedure was used to introduce a radioiodinated tyramine group on a 16mer oligonucleotide d(
Enzymatic degradation of the iodinated oligonucleotide 6 was performed in order to check the specificity of the radiolabelling on the tyramine residue as previously described (43) . Briefly, a solution of 20 /tg of Penicillium citrium nuclease PI in 60 /il 6.6mM ZnSO 4 , 0.18 M sodium acetate buffer, pH 5.3 was mixed with *Tya-19mer-RSSR-OH 7 (0.6 MBq) in 10 mwater and kept for 1 h at 20°C. Then, the solution pH was raised up to 8 by adding 1 M Tris and 20 /tl calf intestine alcaline phosphatase was added. The solution was kept at 37°C for 2h, then heated at 100°C for 5 min. Released products were analyzed by thin layer chromatography, using isopropanol/ammoniac/water (7:1:2, per volume) as solvent.
Preparation of BSA and M6P-BSA bearing dithiopyridinyl residues. M6P, 6 -, PDPu-BSA and PDP m -BSA were prepared as previously described (44) by using SPDP (45) . In order to prepare conjugates with stable disulfide bridges, M6P|g-BSA and BSA were substituted with eight 4-carbonyl-a-methyl-a-(2-pyridinyldithio)-toluene (MPT) residues by using 4-succinimidyloxycarbonyla-methyl-a (2-pyridinyldithio)-toluene (SMPT) (46) , leading to M6Pi6-, MPTgBSA and MPT g -BSA, respectively. The number of sugar residues bound per BSA molecule was determined by the resorcinol/sulfuric acid method (47) and the number of PDP or MPT molecules bound per BSA or M6P-BSA molecules were determined from absorbance at 343 nm in the presence of DTT (45) . DTT (3 mg; 19 /tmol) for 6 h at 20°C under nitrogen to generate a 3'-thiol function. DTT and HS-R-OH were then removed by five extraction with 2 ml ethyl acetate (saturated with H 2 O and outgassed by bubbling nitrogen). The radiolabelled oligonucleotide 8 (*Tya-19mer-RSH) was added dropwise to 2mg (0.025 mmol) M6P, 6 -, PDP 15 -BSA or PDP 10 -BSA in 0.5 ml, 0.1 M NaCl, 1.7 M EDTA, 0.1 M sodium phosphate buffer, pH 7.2. Similarly, the fluoresceinylated oligomer 5 (F-19mer-RSH, 0.8 mg; 0.12 mmol) was added dropwise to M6P 16 -, MPT 8 -BSA or MPT 8 -BSA (2 mg; 0.025 /imol). The reaction was conducted for 6 h at 20°C under nitrogen. Conjugates were purified by gel filtration on Sephadex G75 column (1 cmx25 cm) in PBS.
Preparation of oligonucleotide-neogtycoprotein conjugates.
The purity of each conjugate was checked by gel electrophoresis on 20% PAGE Fastgel using 'native' buffers strips (Pharmacia). The gels were fixed for 30 min in 20% acetic acid, 5% glycerol solution, and dried in air. Fluorescent compounds were revealed by silver staining while radiolabelled products were revealed by autoradiography forlOhat-80°C using Fuji X-ray films.
Protein concentration was determined according to the Bradford method (48) . The number of radioactive oligonucleotide molecules per conjugate molecule was calculated by measuring the radioactivity of the oligonucleotide-neoglycoprotein conjugate.
The number of fluorescenylated oligonucleotide molecules per conjugate molecule was determined by measuring the fluorescence intensity at 520 nm upon excitation at 495 nm of a solution of oligonucleotideneoglycoprotein conjugate pretreated with 0.1 M DTT for 2h. The fluorescence intensity of 1 /ig/ml fluoresceinylated oligonucxleotide was used as standard.
OUgonucleotides and conjugates stability in culture media. Radiolabelled oligomer 7 (*Tya-19mer-RSSR-OH) free and bound to M6P-BSA (M6P I6 -, [*Tyal9mer],. 3 -BSA) were incubated at 37°C in 200 jil of MEM medium supplemented with 5% of heat inactivated fetal bovine serum. Aliquots (10 /tl) were collected every 2 h and immediately frozen at -20°C. Samples were concentrated by using a speed-vac concentrator (Savant instruments, N.Y., USA) and analyzed by 20% PAGE electrophoresis in the presence of 7 M urea (running conditions: 2000 V for 30 min and 2 h at 1500 V). Gels were dried and revealed by autoradiography at -80°C for 10 h.
Cells
Peritoneal macrophages. (C57BL/6xBalb/c) F, mice ( 6 -7 weeks old) purchased from CSEAL (CNRS,Orleans, France) were injected with 2 ml thioglycolate medium (Institut Pasteur, Paris, France). Four days later, peritoneal macrophages were harvested by three lavages of the peritoneal cavity with 5 ml RPMI 1640. Cells were spun down and resuspended in 1 mM CaCl 2 , 0.5 mM MgCl 2 PBS containing 1% BSA at pH 7.4 (complete PBS).
Cultured cells. Human promonocytes (U937 cells), kindly provided by Dr. L. Gazzolo (Lyon, France), were grown in suspension in RPMI 1640 medium. The murine macrophage cell line J774 clone E (J774E) cells kindly provided by Dr. P. Stahl (Saint Louis, MO, USA) (35) and baby hamster kidney cells, BHK cells were cultured in monolayers in RPMI 1640 and in MEM media, respectively. The media were supplemented with 2 mM L-glutamine, 100 units//tl penicillin, 0.1 /ig/ml streptomycin and 10% of heat inactivated fetal bovine serum.
Cells were grown at 37° C in a humidified atmosphere containing 5% CO2 and 95% air and were Mycoplasma free as evidenced by using BVC-kanamycin A staining method (49) . Adherent cells were harvested during their exponential growing phase by treatment with 2.5 /tg/ml trypsin and 0.02% (w/v) EDTA in PBS.
Cellular uptake of free or conjugated radiolabelled oligonucleotides. Cells (2 X lOVwell) were incubated either at 4°C or at 37 °C in a microtitration plate previously coated with BSA (2% in PBS for 1 h at 37°C) with 200 /tl PBS containing different concentrations of radiolabelled oligonucleotide either free or bound to 6-phosphomannosylated BSA. After 2 h, the cells were harvested by gentle pipetting, put onto 150 /xl dibutylphtalate/ bis(2-ethylhexyl)phthalate (3:1; v/v) mixture in a 500 /*! propylene tube and centrifuged for 5 min at 10 000 g (Beckman Microfuge, Gagny, France) in order to remove unbound ligands (50) . The tube tip, containing the cell pellet, was cut and the cell associated radioactivity was counted in a LKB 1282 Compugamma counter (Pharmacia). Confocal microscopy. J774E cells were plated on glasses (2x lO'/slide) and cultured for further 24 hr. Then the culture medium was discarded, cells were washed with complete PBS containing 1 % BSA and incubated for 3 h at 37°C with 2.5 /*M fluoresceinylated 19mer oligonucleotide either free or bound to BSA or to M6P-BSA. Cells were washed with PBS to remove unbound ligands, fixed with 1 % /^-formaldehyde in PBS for 1 h at room temperature and mounted in a PBS/glycerol mixture (1:1; v/v) containing 1 % of DABCO (Sigma) as an anti fading agent (52) . Cells were analysed with a confocal fluorescence microscope (Lasersharp MRC-600, Bio-Rad, Oxfordshire, England) at 488 nm from an Argon laser.
RESULTS
In order to increase the cellular uptake of oligonucleotides, oligonucleotides were coupled to neoglycoproteins specifically endocytosed via membrane lectins of macrophages. Mannose-6-phosphate was chosen instead of mannose in order to target macrophages as well as their precursors (monocytes, U937 cells) which are known to have no mannose receptor on their surface but to express one mannose-6phosphate specific lectin. To follow the cellular uptake, conjugates bearing either fluorescent or radioiodinated oligonucleotides were prepared.
Oligonucleotide synthesis (F-19mer-RSSR-OH 4; *Tya-19mer-RSSR-OH 7)
. An oligonucleotide d^'AAGCTTTATTGAGGC-TTAA 3 ') complementary to the [+64,+83] sequence of LTRHJV-BRU and bearing a disulfide bridge on its 3' end was synthesized by solid phase synthesis using a previously described solid support (40) . This oligonucleotide was modified on the 5'-end in order to introduce either a fluoresceinyl or a phenolic residue. The 5'-OH group of the oligonucleotide still attached on the solid support 1 was activated with CDI (2) (fig 1A) .
F-19mer-RSSR-OH 4.
FTTC was coupled on an aminohexamethylene arm introduced at the 5'-end of the oligonucleotide via a non-biodegradable carbamate linkage as shown in figure IB.
*Tya-19mer-RSSR-OH 7.
A tyramine group, which can be easily iodinated was introduced at the 5'-end of the oligonucleotide using a two step procedure (see fig 1C) . After complete deprotection, compound 6 (Tya-19mer-RSSROH) was easily separated from 19mer-RSSR-OH oligonucleotide by reverse phase HPLC ( fig  IE) and was obtained in a 80% yield. 
Oligonucleotide-protein conjugates M6P-, [*Tya-19mer]-BSA, *Tya-19mer-BSA conjugates and M6P-, [F19mer]-BSA, [F-19-mer]-BSA conjugates.
Oligonucleotides with a thiol group at their 3' end were coupled to BSA and M6P-BSA bearing pyridyldithiopropionyl groups introduced by using either SPDP or SMPT: The 3'-thiol function of F-19mer-RSSR-OH 4 and of *Tya19mer-RSSR-OH 7 was produced by reduction of the disulfide bridge with DTT. The reaction was monitored by reverse phase HPLC. As shown in fig ID, the F-19mer-RSH 5 was eluted before its precursor F-19mer-RSSR-OH 4. The 3'-thiol function was reacted with BSA or M6P-BSA bearing dithiopyridinyl groups, leading to conjugates with 1 or 2*Tya oligonucleotides and about 1 F-oligonucleotide per BSA or M6P-BSA molecule.
The purity of each conjugate and the nature of the linkage between oligonucleotide and protein were checked by 20% polyacrylamide gel electrophoresis before and after reduction with DTT (fig 2A and 2B) . The radiolabelled compound corresponding to *Tya-19mer bound to M6P-BSA (fig 2A, lane 1) upon DTT treatment migrated ( fig 2B, lane 1) with the rate of *Tya-RSH ( fig 2B, lane 3) showing that the radiolabelled oligonucleotide was initially linked to M6P-BSA by a disulfide bridge sensitive to DTT.
Oligonucleotides and conjugates stability in culture medium
The stability of oligonucleotide bound to M6P-BSA in culture medium was monitored by PAGE. M6P-, [*Tya-19mer]-BSA was incubated at 37°C in MEM medium supplemented with 10% heat inactivated fetal bovine serum. Aliquots were collected upon incubation for 2 or 4h and analyzed by electrophoresis (fig 3) . In the presence of heat inactivated fetal bovine serum, the radioactivity did not leave the radiolabelled oligonucleotide- neoglycoprotein conjugates (fig 3) showing that the oligonucleotide was neither released as such from the conjugate nor released as small parts upon a putative endonuclease action. Similar results were obtained upon incubation in the presence of mouse serum (data not shown). These data showed that, in a culture medium, i) an oligonucleotide protected at both 5'-and 3'-ends is prevented from nuclease activities, ii) the disulfide bridge between the oligonucleotide and the protein is stable.
Cell association of radiolabelled 19mer oligonucleotide free or bound to M6P-BSA
The amount of cell-associated oligonucleotide was assessed upon incubation at 4°C with the 19mer oligonucleotide free or bound to M6P-BSA. M6P-BSA specifically bind M6P specific membrane lectins present on the cell surface of the selected target cells. The amount of the radiolabelled 19mer oligonucleotide bound at the cell surface of murine peritoneal macrophages upon incubation at 4°C was lightly higher when cells were incubated with the 19mer oligonucleotide-neoglycoprotein conjugate than with the free 19mer oligonucleotide (fig 4) : the plateau was reached when cell were incubated with 0.35 ^M conjugate. Upon incubation at 37°C with the free 19mer oligonucleotide to allow endocytosis, the cell-associated oligonucleotide did not significantly increase, whereas incubation at 37°C with M6P-, *Tya-19mer-BSA a large amount of oligonucleotide was associated with macrophages ( fig 4) . Experiments were conducted with other cells expressing M6P membrane lectins, such as the promonocytic cell line U937 and the fibroblast-like BHK cells (fig 5) . Although U937 are known to express M6P receptors on their surface (53), most of the M6P receptors are located on the intracellular membranes and consequently these cells poorly internalized M6P bearing proteins, and the uptake of 19 mer oligonucleotide coupled to M6P-BSA was only 1.5 higher than that of free 19mer oligonucleotide. After substracting the amount of oligonucleotide bound to U937 cells upon incubation at 4°C, the intracellular concentration of 19mer oligonucleotide free or bound to M6P-BSA was estimated, assuming a cell volume of 1.76x 10~6 /il (15 /tm diameter) to be about 0.032 /tM and 0.055 /tM, respectively ( fig 5) . Therefore, the oligonucleotide concentration was not significantly different. In contrast, BHK cells as well as murine peritoneal macrophages accumulated a higher amount of 19mer oligonucleotide when 19mer oligonucleotide was bound to M6PBSA. The oligonucleotide intracellular concentration in BHK cells and in macrophages was 0.73 /iM and 1.7 /iM, respectively, higher than the oligonucleotide concentration in the incubation medium (0.35 /iM). Conversely, with cells incubated with the free 19mer oligonucleotide the intracellular concentration was very low, 0.095 /*M in BHK cells (one fourth of the oligonucleotide concentration in the incubation medium) and 0.03 /tM in 
Uptake of fluoresceinylated conjugates by J774E cells and murine peritoneal macrophages
The uptake of fluoresceinylated oligonucleotides free or bound to either BSA or M6P-BSA was assessed by flow cytometry using a method previously described (25, 51) . J774E cells were incubated at 37°C with 0.35 /xM fluoresceinylated oligonucleotides either free or bound to the neoglycoprotein, the cell fluorescence intensity was measured at different times over a 6 h period, before and after monensin postincubation ( fig 6) . Oligonucleotide internalization upon incubation at 37 °C was demonstrated by the increase of cell associated fluorescence intensity followed by the post-incubation at 4°C in the presence of monensin: because fluorescein fluorescence is quenched in acidic environment, and because the endocytosed material is rapidly associated with acidic vesicles (endosomes and/or lysosomes), monensin is used to raise the intravesicular pH and therefore to overcome the fluorescein fluorescence quenching. The fluorescence of cells incubated with F-19mer oligonucleotide remained low even after 6 h incubation and the fluorescence did not increase after monensin post treatment at 4°C indicating that the oligonucleotide was not or very poorly internalized by an endocytosis process. The cell associated fluorescence upon incubation with oligonucleotide bound to BSA was roughly as the level of that obtained with cells incubated in the presence of free F-19mer oligonucleotide, however the cell associated fluorescence increased after addition of monensin suggesting that the conjugate was internalized into acidic compartments. The uptake of oligonucleotide bound to BSA or to M6P-BSA, measured after monensin post incubation reached a plateau after 4 h of incubation. The fluorecence of J774E cells incubated with the oligonucleotide bound to Man6PBSA was higher than the fluorescence of J774E cells incubated with oligonucleotide bound to BSA before and after monensin post-incubation. Oligonucleotide concentration after 2hr incubation at 37 °C was found to be 0.06 iiM, 0.68 /iM and 1.43 /iM for free oligonucleotide and oligonucleotide bound to BSA and M6PBSA, respectively. This significant increase of oligonucleotide uptake is in agreement with an endocytosis process mediated by mannose-6-phosphate specific membrane lectins of J774E cells. Similar results were obtained with murine peritoneal macrophages incubated for 2h with oligonucleotide bound to BSA or Man6P-BSA: the fluorescence increased after monensin post incubation and the cellassociated fluorescence was 7 and 12 times higher when macrophages were incubated with 1 /*M F19mer oligonucleotide bound to BSA and M6PBSA respectively than when macrophages were incubated with 1 /iM free 19mer oligonucleotide (data not shown).
Confocal microscopy
The intracellular localization of both free and conjugated oligonucleotide was determined using a fluorescence confocal microscope (fig 7) . J774E cells incubated for 3 h at 37 °C with 2.5 /xM F-19mer oligonucleotide were lightly labelled, fluorescence was mainly located on the plasma membrane and very few vesicles were observed. The fluorescence of cells incubated with 1 /iM F-19mer linked to BSA was similar and located close to the cell periphery , whereas cells incubated with 0.5 iiM F-19mer oligonucleotide conjugated to M6P-BSA were strongly fluorescent and the fluorescence was mainly located in vesicules.
DISCUSSION
A 19mer oligodeoxyribonucleotide was synthesized and modified on both the 3' and 5'-ends. The oligonucleotide was substituted at the 3'-end by a thiol group in order to couple it onto a protein carrier bearing activated thiol groups. The 5'-end was either fluoresceinylated or radioiodinated to monitor oligonucleotide internalization into the cells. A new simple method was used to radioiodinate the oligonucleotide. Generally, TiCLj or iodogen are used to radioiodinate cytosine of DNA or RNA (54, 55) . Knowing that carbone-iode bond in a benzene ring is more stable than in heterocycles, p-methoxyphenyl groups (56) or tyramine (57), coupled to a cytosine residue, have been introduced into oligonucleotides as iodinable aromatic groups. In this paper a tyramine was introduced at the 5'-end of the oligonucleotide via a carbamate linkage, at the last step of the synthesis on solid phase. The oligodeoxyribonucleotide 5'-end still linked on the support was selectively detritylated, the free 5'-hydroxyl group was activated with CDI and tyramine was added. 5'-Tyramine derivatized oligonucleotides were obtained with a 75% yield and the method is suitable to prepare such derivative by using an automatic DNA synthesizer.
The 5'-radioiodinated or 5'-fluoresceinylated oligodeoxyribonucleotides were conjugated to 6-phosphomannosylated BSA via a disulfide bridge using either SPDP (44) or SMPT to obtain more stable disulfide linkages (46) . In average, 1 or 2 oligonucleotide molecules were bound onto BSA and M6P-BSA bearing PDP or MPT groups. This type of linkage has been largely used in drug targeting to prepare immunotoxins and was shown to be cleaved inside the cells. Shen et al (58) reported that MTX linked to undegradable poly(D-lysine) via a disulfide bridge was as toxic as MTX bound onto poly(L-lysine) via an amide linkage, showing an intracellular reduction of the disulfide. Recently, the same authors showed that cleavage of the disulfide began near the cell surface during the first step of endocytosis , and occur also later in the Golgi apparatus (59) . A plant toxin, gelonin, a strong inhibitor of protein synthesis in a cell-free system, but a mild inhibitor of cells was found to be 100 fold more toxic as a gelonin-neoglycoprotein conjugate because of selective endocytosis via membrane lectins of Lewis lung carcinoma cells (24) .
Unmodified oligonucleotides are usually completely degraded within 15 min in calf serum (60) , on the contrary oligonucleotides modified at both 3' and 5'-ends are stable in culture medium. In culture media, the oligonucleotide stability depends mainly on 3'-exonuclease and to a lesser extend to the 5' exonuclease activity (1) . We show here that the conjugate, in which the 5'-radioiodinated oligodeoxyribonucleotide is bound onto a protein (BSA or M6P-BSA) via a disulfide linkage is stable in the culture medium supplemented with 10% heat inactivated fetal bovine serum i.e, the disulfide bridge is not reduced and the oligonucleotide remains intact. Oligonucleotides (0.35 fiM) are slowly taken up by cells, independently of the cell type (macrophages, J774E, BHK, or U937 cells), the uptake of the 19mer oligonucleotide remained very low even upon 24 h incubation. The internalization of this oligonucleotide coupled to M6P-BSA was higher than the uptake of free oligonucleotide and depended upon the cell type: macrophages internalized twice more conjugates than BHK and 30 fold more than U937 cells. The cellular uptake of oligonucleotide M6PBSA conjugate was mediated by mannose-6-phosphate membrane lectins present at the surface of each cell type. These results are in agreement with the endocytosis capacity of these cells which is high with macrophages, moderate with BHK and low with U937 cells as demonstrated by using fluoresceinylated neoglycoproteins. When cells are incubated with oligonucleotide at micromolar concentration, the oligonucleotide concentration inside the cells is about 10% of the concentration in incubation medium (61, 4) . Accordingly, when macrophages or the murine macrophage cell line, J774E, are incubated for 2 h with 0.35 /tM of fluoresceinylated or radiolabeled 19mer oligonucleotide, the intracellular concentration of the oligomer was very low (0.04-0.06 nM). Under the same conditions, the 19mer bound onto M6P-BSA was internalized through their membrane lectins, leading to a high intracellular concentration (1.43 to 1.7 iiM), i.e the intracellular concentration was 4-to 5-fold higher than the extracellular concentration. Therefore the use of Man6P-BSA as a cell specific carrier in cells expressing the M6P receptor on their surface improve the uptake about 30-fold. The high level of uptake is in the range of that obtained with oligonucleotide substituted with compounds such as cholesterol, phospholipids or poly(L-lysine) which are not cell specific. Attachment of a cholesterol residue at the 3'-end of a decathymidylate increased the oligonucleotide internalization by a factor of 6 to 8 when 2.5 /tM and 0.5 /iM cholesterol derivatized oligonucleotide were incubated for 2 h with L929 or Krebs-2 cells, respectively (7) . Attachment of a phospholipid to the 5'-end of a 15mer oligonucleotide increased 10 fold its cellular uptake after a 4 h incubation (10) . Attachment of a fluoresceinylated 15 mer oligonucleotide to poly(L-lysine) increased 12 fold its internalization by L929 cells (12) . Recently, the uptake by brain capillaries of a biotinylated 21 mer antisense oligonucleotide was increased 4 fold when the biotinylated oligomer was complexed with avidin (62) . In this last case, it is the cationic property of avidin which mediates the uptake as in the case of polylysine. The above modifications increased the oligonucleotide cellular uptake, but did not provide a selective targeting; conversely glycoconjugates which are recognized by specific membrane lectins are expected to selectively target specific cells. The cellular uptake of antisense oligonucleotides linked to glycosylated macromolecules was highly increased in comparison with the uptake of free oligonucleotides. Studies using fluorescence confocal microscopy showed that the fluoresceinylated oligonucleotide was mainly associated with vesicular compartments as expected from an endocytotic process. However as it is difficult to quantitate the dull fluorescence found in the cytosol, we are now assessing the amount of oligonucleotide present in the cytosol and/or in the nucleus of cells previously incubated with radiolabelled oligonucleotides and conjugates, by subcellular fractionations. The uptake of phosphodiester oligodeoxyribonucleotides which has been reported as to be mediated by cell surface molecules acting as oligonucleotide receptors (3), or the uptake of methylphosphonate oligonucleotides which is due to fluid phase endocytosis or even to non-specific adsorbtive endocytosis (63) lead to a distribution of oligonucleotides confined into vesicular compartments. As biological effects have been reported with antisense oligonucleotides directed against viral sequences, it is expected that a small amount of the oligonucleotides which have been taken up into vesicles has reached its target mRNA in the cytosol after crossing an intracellular membrane. It could be expected that increasing the intracellular concentration may also result in increasing the amount of oligonucleotide able to cross a membrane to reach the cytosol. The 19mer oligonucleotide with a sequence complementary to a part of the LTRHJV, and the oligonucleotide-neoglycoprotein conjugates are being tested on macrophage like cells transfected with LTR Hrv governing the luciferase gene, as reporter gene.
